Anti-S. aureus ClfA (Tefibazumab)-MC-Vc-PAB-MMAE ADC
CAT:
ADC-W-2135
Taille:
1 mg
Prix:
---
Qty:
Disponibilité et expédition
- Articles en stock livrables sous 24 à 48 heures et articles hors stock livrables sous 2 à 6 semaines
- Glace carbonique: Not Required
Description du produit
This ADC product is comprised of an anti-S. aureus ClfA monoclonal antibody conjugated via a MC-Vc linker to MMAE. The MMAE is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Propriétés du produit
DangereuxNo
Glace carbonique requiseNo
Marque déposéeNo